Crdl stock price volatility has increased over the past

CRDL stock price volatility has increased over the past two weeks, driven by news on clinical trial progress. If momentum continues, traders could see a retest of the previous 30-day high. Investors are advised to track moving averages for directional bias. While Cordel Group Plc ( LON:CRDL ) might not have the largest market cap around , it led the AIM gainers with a relatively large price hike in the past couple of weeks. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today we will analyse the most recent data on Cordel Group’s outlook and valuation to see if the opportunity still exists. Cardiol Therapeutics ( (TSE:CRDL) ) has issued an update. The latest CRDL stock price is showing signs of short-term consolidation, trading around recent support levels. Market analysts are closely watching volume trends and institutional activity as signals for potential breakout opportunities in the biotech sector.